Inactivation of glycogen synthase kinase-3beta protects against kainic acid-induced neurotoxicity in vivo

Brain Res. 2004 Nov 5;1026(1):116-25. doi: 10.1016/j.brainres.2004.08.021.

Abstract

Many neurodegenerative diseases involve oxidative stress and excitotoxic cell death. In an attempt to further elucidate the signal transduction pathways involved in the cell death/cell survival associated with excitotoxicity, we have used an in vivo model of excitotoxicity employing kainic acid (KA)-induced neurotoxicity. Here, we show that extracellular signal-related kinase (ERK) 2, but not ERK 1, is phosphorylated and thereby activated in the hippocampus and cerebellum of kainic acid-treated mice. Phosphorylation and hence inactivation of glycogen synthase kinase 3beta (GSK-3beta), a general survival factor, is often a downstream consequence of mitogen-activated protein kinase pathway activation. Indeed, GSK-3beta phosphorylation occurred in response to kainic acid exclusively in the affected hippocampus, but not as a consequence of ERK activation. This may represent a compensatory attempt at self-protection by the cells in this particular brain region. A role for GSK-3beta inhibition in cell survival was further supported by the fact that pharmacological inhibition of GSK-3beta using lithium chloride was protective against kainic acid-induced excitotoxicity in hippocampal slice cultures. This work supports a role for GSK-3beta in cell death in response to excitotoxins in vivo and further confirms that GSK-3beta plays a role in cell death/cell survival pathways.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal
  • Blotting, Western / methods
  • Butadienes / therapeutic use
  • Cell Death / drug effects
  • Cell Survival / drug effects
  • Cerebellum / drug effects
  • Cerebellum / metabolism
  • Cerebellum / pathology
  • Enzyme Activation
  • Enzyme Inhibitors / therapeutic use*
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors*
  • Glycogen Synthase Kinase 3 / physiology
  • Glycogen Synthase Kinase 3 beta
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Immunohistochemistry / methods
  • Kainic Acid
  • Lithium Chloride / therapeutic use
  • Male
  • Mice
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Neurotoxicity Syndromes / etiology
  • Neurotoxicity Syndromes / prevention & control*
  • Nitriles / therapeutic use
  • Organ Culture Techniques
  • Phosphorylation / drug effects
  • Serine / metabolism
  • Tetrazolium Salts
  • Thiazoles
  • Time Factors
  • Tyrosine / metabolism

Substances

  • Butadienes
  • Enzyme Inhibitors
  • Nitriles
  • Tetrazolium Salts
  • Thiazoles
  • U 0126
  • Tyrosine
  • Serine
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, mouse
  • Mitogen-Activated Protein Kinase 1
  • Glycogen Synthase Kinase 3
  • thiazolyl blue
  • Lithium Chloride
  • Kainic Acid